Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1310094/000121465913003905/c7151328k.htm
March 2013
February 2013
November 2012
October 2012
August 2012
June 2012
June 2012
March 2012
Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1310094/000121465913003905/c7151328k.htm
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Accentia Biopharmaceuticals Inc.
Accentia Biopharmaceuticals Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2013 10-K Annual Report includes:
CIK: 1310094Events:
Form Type: 8-K Corporate News
Accession Number: 0001214659-13-003905
Submitted to the SEC: Mon Jul 15 2013 4:40:03 PM EST
Accepted by the SEC: Mon Jul 15 2013
Period: Wednesday, March 6, 2013
Industry: Pharmaceutical Preparations